Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades
- 1 December 1993
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 75 (3), 195-206
- https://doi.org/10.1016/0304-3835(93)90062-e
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Detection of the HER-2/neu proto-oncogene protein p185erbB2 by a novel monoclonal antibody (MAB-145ww) in breast cancer membranes from oestrogen and progesterone receptor assaysEuropean Journal Of Cancer, 1992
- Tamoxifen up-regulates c-erbB-2 expression in oestrogen-responsive breast cancer cells in vitroEuropean Journal Of Cancer, 1992
- Cathepsin D assay in primary breast cancer and lymph nodes: Relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasivenessEuropean Journal of Cancer and Clinical Oncology, 1990
- Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significanceInternational Journal of Cancer, 1989
- c-erbB-2 expression in benign and malignant breast diseaseBritish Journal of Cancer, 1988
- An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinomaBritish Journal of Cancer, 1988
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986
- Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu OncogeneScience, 1985
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Histological Grading and Prognosis in Breast CancerBritish Journal of Cancer, 1957